Opthea Ltd OPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/05/21 EST
9.25quote price arrow down-0.10 (-1.07%)
Volume
7,525
52 week range
8.98 - 17.86

...

Loading . . .

KEY STATS

  • Open9.42
  • Day High9.42
  • Day Low8.98
  • Prev Close9.35
  • 52 Week High17.86
  • 52 Week High Date10/12/20
  • 52 Week Low8.98
  • 52 Week Low Date03/05/21
  • Market Cap384.55M
  • Shares Out42.21M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Opthea Ltd News

There is no recent news for this security.

Latest OPT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Opthea Limited, formerly Circadian Technologies Limited, is engaged in developing and commercializing therapies primarily for eye diseases. The Company operates in medical technology and healthcare industry in Australia. The Company is involved in the development activities, which are based on the intellectual property portfolio covering key targets, such as vascular endothelial growth factors [VEGF]-C, -D and VEGF Receptor-3 for the treatment of diseases associated with...
Jeremy Levin
Chairman
Megan Baldwin Ph.D.
Chief Executive Officer
Michael Tonroe
Chief Financial Officer
Address
Se 403 L 4, 650 Chapel St
Melbourne, VIC
3141
Australia